Geoffrey M. Cooper is a retired cancer researcher and scientific administrator, having held positions as a professor, department chair and associate dean at Harvard Medical School and Boston University. He is the author of several scientific texts and is now using his experience in academic medicine as background for writing fiction. His debut novel is the award-winning medical thriller, The Prize.
“An intense story about ruthlessness in the scientific community.”
– Kirkus Reviews
A professor joins the world of academic espionage to track down stolen genetic research in this science-based thriller sequel.
In his third novel, Cooper brings back characters from his previous novel, Nondisclosure (2019): Academic Brad Parker and university detective Karen Richmond, and the latter is now a senior special agent with the FBI. After helping Richmond solve a sexual assault and murder case on his home campus, Boston Technical Institute, Parker is on sabbatical at Harvard University exploring gene manipulation. To his dismay, however, the FBI wants him to help catch Chinese spies posing as university students. Parker initially dismisses the agents’ claims as bigotry, but agrees to report any suspicious activity. With this premise, Cooper, an academic whose former affiliations include Boston University and Harvard Medical School, sets up a mystery that makes genetic engineering accessible to reader via first-person narration. For instance, during a fundraising dinner, Parker remarks that a potential donor “perked up quickly when Alice [a colleague] started showing our data on telomere length” before asking if “the ends of the chromosomes in your treated mice actually got longer...as if the mice are getting younger?” Using minimal technical terminology and nesting the science within conversation helps the novel seem authoritative without alienating readers. Cooper also uses extended scenes to heighten suspense; for example, while researching, Parker comes across papers concerning “experiments in which old mice were given infusions of blood plasma from young mice—with the result that the performance of the old mice in learning and memory tests significantly improved.” Instead of keeping the pace of the novel consistent by simply summarizing, Cooper ratchets up the tension by teasing out Parker’s discovery of a pivotal clue. Although the mystery plot would have benefited from more red herrings, the novel as a whole comes off as an effective medical mystery.
A persuasive tale of scientific intrigue.
Pub Date: May 15, 2020
Page count: 198pp
Publisher: Maine Authors Publishing
Review Posted Online: May 15, 2020
Three scientists strive to find the cure for Alzheimer’s in Cooper’s (The Cell: A Molecular Approach, 2015, etc.) scientific thriller.
Forty-seven-year-old Eric Prescott is an accomplished scientist specializing in Alzheimer’s disease research at the Institute for Advanced Neuroscience in Cambridge, Massachusetts. The novel opens with a conversation between Eric and some scientists after he accepts the Lasker Award for “seminal research in elucidating the basis of Alzheimer’s disease.” Eric’s arrogance is apparent when one of the Karolinska Institute professors on the Nobel Committee, Alfred Bergner, recommends that Prescott speak to another scientist, Pamela Weller: “Prescott was steaming. Did Bergner seriously think this woman was some kind of competition?” Pam is a faculty member in the Langmere Institute for Neurological Disease at Harvard University. When her research results in what may be the key to the cure, Holly Singer, one of her postdocs, teams up with Eric to claim the breakthrough as their own, and they take extreme measures to ensure their place in history and receive the Nobel Prize. The omniscient narration makes each major character’s intentions clear: Pam wants to make a difference, Eric wants fame, and Holly wants to establish herself as a respected voice in the scientific community. One of the highlights of this book is how comfortably Cooper manages to find a balance in presenting difficult scientific topics in an easy-to-follow narrative, as when Holly explains a cell culture: “They’re cells that were triggered to start producing Alzheimer’s plaque. You can see the plaques have formed and the cells are beginning to die.” The characters do come off as a little one-dimensional, however, and the book might have benefited from additional back story, such as how Pam became so interested in Alzheimer’s research. Nonetheless, this is an engrossing read; in one particularly suspenseful moment, a character awaits the results of putting Nembutal in another’s wine.
An intense story about ruthlessness in the scientific community.
Pub Date: Jan. 15, 2018
Page count: 240pp
Review Posted Online: Nov. 24, 2017
Hey there, book lover.
We’re glad you found a book that interests you!